146 related articles for article (PubMed ID: 32196599)
1. LINC00657 promotes malignant progression of oral squamous cell carcinoma via regulating microRNA-150.
Xu FY; Xu X; Hu XD
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2482-2490. PubMed ID: 32196599
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of lncRNA FEZF1-AS1 in promoting the occurrence and development of oral squamous cell carcinoma through targeting miR-196a.
Xu L; Hou TJ; Yang P
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6505-6515. PubMed ID: 31378890
[TBL] [Abstract][Full Text] [Related]
3. LncRNA FAL1 promotes the development of oral squamous cell carcinoma through regulating the microRNA-761/CRKL pathway.
Ye J; Jiao Y
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5779-5786. PubMed ID: 31298329
[TBL] [Abstract][Full Text] [Related]
4. LncRNA LACAT1 promotes proliferation of oral squamous cell carcinoma cells by inhibiting microRNA-4301.
Wang J; Huo F; Wang XR; Xu YY
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2427-2435. PubMed ID: 30964168
[TBL] [Abstract][Full Text] [Related]
5. CSN6 promotes malignant progression of oral squamous cell carcinoma by down-regulating TIMP-2.
Gao WY; Yang G; Wang J; He JM; Wang P
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5419-5428. PubMed ID: 32495877
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-378 promotes the malignant progression of oral squamous cell carcinoma by mediating FOXN3.
Ding N; Luo M; Liao XL; Bao QY; Li RY; Wu B
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(14):6202-6210. PubMed ID: 31364120
[TBL] [Abstract][Full Text] [Related]
7. LncRNA SNHG14 promotes proliferation of endometrial cancer through regulating microRNA-655-3p.
Wang GF; Wen LN
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10410-10418. PubMed ID: 33155197
[TBL] [Abstract][Full Text] [Related]
8. LncRNA TP73-AS1 promotes malignant progression of hepatoma by regulating microRNA-103.
Ma CX; Gao WC; Tian L
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(11):4713-4722. PubMed ID: 31210297
[TBL] [Abstract][Full Text] [Related]
9. LncRNA WTAPP1 promotes proliferation of laryngeal carcinoma cells through regulating microRNA-592.
Shi XY; Lin JJ; Ge XJ; Shi Y
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9532-9540. PubMed ID: 33015795
[TBL] [Abstract][Full Text] [Related]
10. Low expression of lncRNA MEG3 promotes the progression of oral squamous cell carcinoma by targeting miR-21.
Zhang LL; Hu D; Zou LH
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8315-8323. PubMed ID: 30556872
[TBL] [Abstract][Full Text] [Related]
11. LncRNA SNHG20 enhances the progression of oral squamous cell carcinoma by regulating the miR-29a/DIXDC1/Wnt regulatory axis.
Chen ZF; Wang Y; Sun LL; Ding SY; Jinag H
Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5436-5445. PubMed ID: 32495922
[TBL] [Abstract][Full Text] [Related]
12. CircRNA_002178 promotes the proliferation and migration of oral squamous cell carcinoma cells by activating the Akt/mTOR pathway.
Yang Y; Ci HS; Mao YL; Li JW; Zuo JH
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6122-6130. PubMed ID: 32572877
[TBL] [Abstract][Full Text] [Related]
13. LINC01551 promotes metastasis of nasopharyngeal carcinoma through targeting microRNA-132-5p.
Xue MY; Cao HX
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3724-3733. PubMed ID: 32329849
[TBL] [Abstract][Full Text] [Related]
14. LncRNA HOXA-AS2 regulates microRNA-216a-5p to promote malignant progression of non-small cell lung cancer.
Cui TJ; Lin GS; Dai YM; Zheng JP; Chen Z; Chen Q; Zheng Y; Lin X
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(3 Suppl):264-273. PubMed ID: 31389597
[TBL] [Abstract][Full Text] [Related]
15. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
Chen AY; Zhang K; Liu GQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
[TBL] [Abstract][Full Text] [Related]
16. Circ-ABCB10 accelerates the malignant progression of oral squamous cell carcinoma by absorbing miRNA-145-5p.
Chen F; Li XH; Liu C; Zhang Y; Wang RJ
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):681-690. PubMed ID: 32016969
[TBL] [Abstract][Full Text] [Related]
17. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression.
Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B
Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238
[TBL] [Abstract][Full Text] [Related]
18. LncRNA SNHG20 promotes the development of laryngeal squamous cell carcinoma by regulating miR-140.
Li Y; Xu J; Guo YN; Yang BB
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3401-3409. PubMed ID: 31081112
[TBL] [Abstract][Full Text] [Related]
19. LncRNA MINCR promotes the development of liver cancer by regulating microRNA-107/β-catenin.
Li H; Yuan R; Wang H; Li C; Wei J
J BUON; 2020; 25(2):972-980. PubMed ID: 32521894
[TBL] [Abstract][Full Text] [Related]
20. LncRNA SNHG17 promotes the progression of oral squamous cell carcinoma by modulating miR-375/PAX6 axis.
Tong F; Guo J; Miao Z; Li Z
Cancer Biomark; 2021; 30(1):1-12. PubMed ID: 32924983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
